AUBREY CAPITAL MANAGEMENT LTD – Halozyme Therapeutics, Inc. Transaction History
AUBREY CAPITAL MANAGEMENT LTD portfolio value:
$442,808
portfolio value
AUBREY CAPITAL MANAGEMENT LTD quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -49.94K | $39.54 | 11.19K | |
| Q2 2022 | share | 0.00% | 0 shares | 45.75K | $44 | 11.19K | |
| Q1 2022 | share | Increase | +25.85% | 2.3K shares | 89.17K | $39.88 | 11.19K |
| Q4 2021 | share | 0.00% | 0 shares | -4.18K | $40.32 | 8.89K | |
| Q3 2021 | share | Decrease | -16.70% | -1.78K shares | -123.10K | $40.68 | 8.89K |
| Q2 2021 | share | 0.00% | 0 shares | 39.74K | $45.41 | 10.68K | |
| Q1 2021 | share | Increase | +51.70% | 3.64K shares | 144.61K | $41.69 | 10.68K |
| Q4 2020 | share | Increase | 0.00% | 7.04K shares | 300.76K | $42.71 | 7.04K |